“Fast - Tracked for Dogs…Delayed for Cats? The NGF Drug Scandal Regulators Can’t Explain.”

Описание: “Why is Zoetis rushing a brand‑new NGF‑blocking drug for dogs through regulators… while quietly stalling the cat version? After Librela and Solensia harmed thousands of pets, you’d think regulators would be cautious with both. But they’re not. And the contradiction exposes something deeply wrong with this entire system.”
Why are regulators fast‑tracking Lenivia, the new NGF‑blocking drug for dogs, while delaying Portela, the feline version?
After the global backlash against Librela and Solensia, this contradiction raises serious questions about safety, transparency, and the influence of pharmaceutical giants like Zoetis.
In this video, we break down:
• The timeline of Lenivia vs Portela
• Why Solensia was rushed through but Portela is now stalled
• How regulators treat dog vs cat markets differently
• What this means for pet owners
• Why the system seems designed to approve — not protect
If you’ve been affected by Librela or Solensia, or you’re worried about the next wave of NGF‑blocking drugs, this is essential viewing.
📌 Petition to demand accountability [https://chng.it/V8tjFyxV7R]
📌 Share your story in the comments
📌 Subscribe for more investigations and advocacy
#Shadow Wants To Survive Librela #JusticeForShadowTheLab #pets #animals #viralvideos #Librela, #Solensia, #Lenivia, #Portela, #Zoetis, #NGF blockers, #veterinary drug safety, #VMD, #EMA, #pet advocacy, #dog osteoarthritis, #cat osteoarthritis, #monoclonal antibodies, #veterinary scandal, #pet deaths, #adverse reactions. #seniordogs #petcare #pethealth #banngfdrugs